This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) discusses developments in cancer diagnostics and targeted cancer therapy, therapeutics for MDR bacteria, viral vectors, and antibody therapeutics for multiple diseases. Further, innovations in emerging technologies such as synthetic blood and 3D printed implants have also been covered. Use of artificial intelligence/machine learning in drug discovery, viral vector design, and immune profiling are also discussed. Few innovations cover developments in cosmeceuticals for skin and hair care and protein-based sweeteners.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Table of Contents
Innovations in Life Sciences, Health & Wellness
- Adaptive Phage Therapeutics, Md, US
- Merck, Nj, US
- Aurinia Pharmaceuticals, Canada
- Xeris Pharmaceuticals, Il, US
- Biotheryx, US
- Targovax, Norway
- NYU Grossman School of Medicine and Perlmutter Cancer Center, Usa
- Regeneron Pharmaceuticals, US
- Leibniz University, Germany
- Omnix Medical, Israel
- Som Biotech, Spain
- Inte Rna, Netherlands
- Membio, US
- Peking University, China
- University of Florida, US
- Additive Orthopaedics LLC. US
- Mereo Biopharma Group plc, UK
- Cabaletta Bio Inc. Pa,Us
- NGM Biopharmaceuticals Inc. Ca, US
- Redhill Biopharma Ltd. Israel
- Eli Lilly and Company, In, US
- Ocugen, Pa, US
- Turbine Ai, Hungary
- Immunai, US
- Tri-K Industries Inc. US
- Amai Proteins, Israel
Key Contacts
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adaptive Phage Therapeutics, Md, US
- Additive Orthopaedics LLC. US
- Amai Proteins, Israel
- Aurinia Pharmaceuticals, Canada
- Biotheryx, US
- Cabaletta Bio Inc. Pa,Us
- Eli Lilly and Company, In, US
- Immunai, US
- Inte Rna, Netherlands
- Leibniz University, Germany
- Membio, US
- Merck, Nj, US
- Mereo Biopharma Group plc, UK
- NGM Biopharmaceuticals Inc. Ca, US
- NYU Grossman School of Medicine and Perlmutter Cancer Center, Usa
- Ocugen, Pa, US
- Omnix Medical, Israel
- Peking University, China
- Redhill Biopharma Ltd. Israel
- Regeneron Pharmaceuticals, US
- Som Biotech, Spain
- Targovax, Norway
- Tri-K Industries Inc. US
- Turbine Ai, Hungary
- University of Florida, US
- Xeris Pharmaceuticals, Il, US
